Fernando Gomez Garcia

Biomedical Research Intern @ Nephrogen

q5u4ux.vw28y3@qk9y4w0u8qjk9xyu.u57 Sign up to see email

Known information

Graduated from the University of Almería (UAL) in 2020 with a Bachelor's degree in Biotechnology
Obtained a Master's degree in Biochemistry, Molecular Biology and Biomedicine at the Complutense University of Madrid (UCM)
Did his Master's Thesis on genetic editing (CRISPR / Cas9) at the Gene Therapy Laboratory of the Carlos III Health Institute (ISCIII)
Currently doing a Doctorate in Molecular Medicine at the Laboratory of Genetics and Developmental Biology of Kidney Diseases (NefroCHUS) from the Health Research Institute of Santiago de Compostela (IDIS)
Beneficiary of a predoctoral contract
Main theme of his thesis is the application of new genetic editing technologies (base editing and prime editing) in cell models and animals carrying genetic mutations that cause polycystic kidney disease (PKD)
Aims to lay the foundations for developing a gene therapy to improve the quality of life of patients with PKD
Completing a 6-month internship at Nephrogen as part of his doctoral thesis

About Nephrogen

Nephrogen is a healthcare company focused on developing curative gene therapies for kidney diseases, particularly polycystic kidney disease (PKD), using advanced CRISPR-Cas genome editing and novel adeno-associated viruses.

Report inaccurate information